120 related articles for article (PubMed ID: 9826707)
1. Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo.
Maruno K; Absood A; Said SI
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14373-8. PubMed ID: 9826707
[TBL] [Abstract][Full Text] [Related]
2. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways.
Rekasi Z; Varga JL; Schally AV; Plonowski A; Halmos G; Csernus B; Armatis P; Groot K
Peptides; 2001 Jun; 22(6):879-86. PubMed ID: 11390017
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
[TBL] [Abstract][Full Text] [Related]
5. VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells.
Maruno K; Absood A; Said SI
Am J Physiol; 1995 Jun; 268(6 Pt 1):L1047-51. PubMed ID: 7541947
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor regulates adenylate cyclase activity via Gs and Gi1-2 proteins in pancreatic acinar membranes.
Stryjek-Kaminska D; Piiper A; Zeuzem S
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):87-91. PubMed ID: 8645237
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells.
Casibang M; Purdom S; Jakowlew S; Neckers L; Zia F; Ben-Av P; Hla T; You L; Jablons DM; Moody TW
Lung Cancer; 2001; 31(2-3):203-12. PubMed ID: 11165399
[TBL] [Abstract][Full Text] [Related]
8. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody.
Maruno K; Said SI
Life Sci; 1993; 52(24):PL267-71. PubMed ID: 8389407
[TBL] [Abstract][Full Text] [Related]
9. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.
D'Angelo G; Lee H; Weiner RI
J Cell Biochem; 1997 Dec; 67(3):353-66. PubMed ID: 9361190
[TBL] [Abstract][Full Text] [Related]
10. Histamine and the cAMP pathway in the guinea-pig pancreas.
Lajas AI; Pariente JA; Salido GM
Cell Signal; 1995 Jan; 7(1):57-60. PubMed ID: 7538775
[TBL] [Abstract][Full Text] [Related]
11. The opposite effects of cyclic AMP-protein kinase a signal transduction pathway on renal cortical and medullary Na+,K+-ATPase activity.
Bełtowski J; Marciniak A; Wójcicka G; Górny D
J Physiol Pharmacol; 2002 Jun; 53(2):211-31. PubMed ID: 12120897
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GM1 ganglioside expression.
Kaur G; Viallet J; Laborda J; Blair O; Gazdar AF; Minna JD; Sausville EA
Cancer Res; 1992 Jun; 52(12):3340-6. PubMed ID: 1375868
[TBL] [Abstract][Full Text] [Related]
13. Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells.
Lambert HW; Weiss ER; Lauder JM
Dev Neurosci; 2001; 23(1):70-7. PubMed ID: 11173928
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.
Vacas E; Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Schally AV; Prieto JC; Carmena MJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1676-85. PubMed ID: 22728770
[TBL] [Abstract][Full Text] [Related]
15. Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors.
Shafer SH; Phelps SH; Williams CL
Biochem Pharmacol; 1998 Nov; 56(9):1229-36. PubMed ID: 9802335
[TBL] [Abstract][Full Text] [Related]
16. Regulation of VIP gene expression in general. Human lung cancer cells in particular.
Davidson A; Moody TW; Gozes I
J Mol Neurosci; 1996; 7(2):99-110. PubMed ID: 8873894
[TBL] [Abstract][Full Text] [Related]
17. VIP inhibits the proliferation of small-cell and nonsmall-cell lung carcinoma.
Maruno K; Said SI
Ann N Y Acad Sci; 1996 Dec; 805():389-92; discussion 392-3. PubMed ID: 8993419
[No Abstract] [Full Text] [Related]
18. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
19. [Adenylyl cyclase pathway is involved in the regulation of intracellular calcium level regulation in brown preadipocytes].
Dolgacheva LP; Abzhalelov BB; Baumuratov AS; Zinchenko VP; Bronnikov GE
Tsitologiia; 2002; 44(1):56-60. PubMed ID: 11868463
[TBL] [Abstract][Full Text] [Related]
20. Regulation of GH3 pituitary tumour-cell adenylate cyclase activity by activators of protein kinase C.
Quilliam LA; Dobson PR; Brown BL
Biochem J; 1989 Sep; 262(3):829-34. PubMed ID: 2480108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]